Home › NDC Lookup › Ingredients › Bisacodyl › 00904-7142-60
Bisacodyl 10 mg Suppository, 100 suppositories — NDC 00904-7142-60 package photo
Label image from the product's FDA listing (DailyMed) — may show a different pack size or an older label revision.

Bisacodyl 10 mg Suppository, 100 suppositories — NDC 0904-7142-60 (Billing 00904-7142-60)

by Major Pharmaceuticals · 100 BLISTER PACK in 1 CARTON / 1 SUPPOSITORY in 1 BLISTER PACK

This is a package of 100 suppositories of Bisacodyl 10 mg Suppository from Major Pharmaceuticals, no longer marketed (first marketed May 2021), no longer in the FDA NDC Directory; retail pharmacies pay about $0.2969 per suppositorie (NADAC).

NDC 00904-7142-60
🏷️ FDA NDC (as labeled) 0904-7142-60 billing pads the labeler segment with a zero
This package
Contains100 suppositories Cost per ea$0.2969 NADAC Per package$29.69 / 100 suppository Pack sizes2 compare ↓
OTC Discontinued Non-controlled ⚠ Discontinued by firm ⇄ Compare with another NDC
🗂️ FDA directory synced Oct 1, 2026 · this listing last changed Jul 24, 2026 · sources: openFDA · FDA label (DailyMed) · FDA Orange & Purple Book · First Databank · CMS NADAC, ASP, Medicare & Medicaid · RxNorm
📋 All sources & update times →

NDC database record

One package, one record: these facts belong to NDC 0904-7142-60 alone.

Record
FDA NDC Directory package listing · Human OTC drug
Code segments
0904 labeler · 7142 product · 60 package
Listing certified through
Dec 31, 2026
Billing quantity
100 EA per package
Barcode (UPC)
0309047142125
FDA record last changed
Jul 24, 2026
⚠️
Excluded from the active FDA NDC Directory. The labeler reported this product as discontinued, so it is excluded from the active NDC Directory. A label may still appear on DailyMed, but the NDC is no longer in the current FDA NDC Directory. Search the FDA NDC Directory ↗

Identity & classification

Regulatory identifiers FDA, NLM and CMS codes for this package

FDA NDC (as labeled) 0904-7142-60
Product NDC 0904-7142
11-digit billing NDC 00904714260
NCPDP billing unit EA — each (per item)
RxCUI 198509
UNII 10X0709Y6I
UPC 0309047142125
Application # M007
SPL Set ID c194c40c-c732-2f03-e053-2a95a90a7a40
Established class (EPC) Stimulant Laxative
Physiologic effect Increased Large Intestinal Motility; Stimulation Large Intestine Fluid/Electrolyte Secretion
DEA schedule Non-controlled
Marketing category OTC MONOGRAPH DRUG
Marketing status Discontinued
FDA listing status Discontinued by firm
Marketing start 2021-05-05
Route RECTAL
Dosage form SUPPOSITORY
Substance BISACODYL

Drug-database identifiers Medi-Span GPI and First Databank GCN / HICL / AHFS classification

GPI-14 46200010005205
GPI class Bisacodyl
GCN Seq No 002944
GCN 08731
HICL code 001301
Ingredient (HICL) Bisacodyl
HIC1 code Q
Therapeutic class — broad (HIC1) Ear/Eye/Nose/Rectum/Topical/Vagina/Other
HIC2 code Q3
Therapeutic class — intermediate (HIC2) Anal-Rectal Preparations
HIC3 code Q3S
Therapeutic class — specific (HIC3) Laxatives, Local/Rectal
AHFS code 56:12.00.00
AHFS class Cathartics And Laxatives
FDB label name BISACODYL 10 MG SUPPOSITORY
FDB brand name Bisacodyl
Legend status O — Over-the-counter (OTC) drug or device
Quick answers
  • GSN (GCN sequence number): 002944
  • GCN: 08731
  • GPI-14 (Medi-Span): 46200010005205
  • HICL (First Databank): 001301
  • AHFS class code: 56:12.00.00
  • RxCUI (RxNorm): 198509
Why two NDCs? The FDA registers this code as 0904-7142-60 — a 4-4-2 layout, and that's what's printed on the package and shown on DailyMed. For insurance claims, every NDC is standardized to a uniform 11-digit 5-4-2 format by adding a zero to the labeler segment → 00904-7142-60. Same drug, same package — only the format differs.
Where does this data come from?
Identifiers from the FDA openFDA NDC Directory and Structured Product Labeling; RxCUI from RxNorm (NLM); GPI from Medi-Span; GCN / HIC / AHFS / legend from First Databank.

RxNorm drug class

This medicine belongs to the Stimulant Laxative class.

Pharmacologic class Stimulant Laxative
Drug family (ATC) Contact laxatives, Enemas
Where does this data come from?
Therapeutic classes from RxNorm RxClass (U.S. National Library of Medicine) — Established Pharmacologic Class (FDA), ATC drug family (WHO) and mechanism of action, matched by this product’s RxCUI.

Clinical

Label name BISACODYL 10 MG SUPPOSITORY Ingredient Bisacodyl
📖 What it is MedlinePlus · NLM

Rectal bisacodyl is used on a short-term basis to treat constipation. It also is used to empty the bowels before surgery and certain medical procedures. Bisacodyl is in a class of medications called stimulant laxatives. It works by increasing activity of the intestines to cause a bowel movement.

Read the full MedlinePlus article ↗
📗 Our plain-language guide HelloPharmacist
  • It relieves occasional constipation and irregularity. The Fleet enema is also used for fecal impaction and to clear residue after a barium test. It is meant for short-term use.
  • It depends on the form. Tablets usually work in 6 to 12 hours. Suppositories usually work in 15 minutes to 1 hour. The Fleet enema usually works in 5 to 20 minutes.
  • Not right away. Wait at least 1 hour after an antacid or milk before taking tablets. Swallow tablets whole with water and do not chew or crush them.
  • Can I take the tablets with an antacid or milk?
📖 Read our full Bisacodyl guide →
Where does this data come from?
Plain-language summary from MedlinePlus (U.S. National Library of Medicine); supplement & herbal interactions and nutrient depletion data from the Natural Medicines database; our full guide is HelloPharmacist editorial content.

Pricing

A drug doesn't have one price. Each row is a different public payment system, and none is what you'd pay at the counter — that depends on your insurance. The ⓘ on each row explains what it measures.

Price systemPer eaPer package
Retail pharmacies payNADAC · weekly $0.297 $29.69 / 100 suppository
Medicaid paysCMS SDUD · 12 mo No recent Medicaid claims on file for this NDC — rare and low-volume NDCs are suppressed in the public data.
Medicare drug plans payPart D · quarterly No Part D plan price is available for this NDC in our data.
NADAC price history (per ea) — tap or hover for the price & month
Feb 2022 May 2022 Aug 2022 Nov 2022 $0.328 $0.241
▲ Up 16% over the last 10 months.
Where does this data come from?
NADAC (National Average Drug Acquisition Cost) is the CMS weekly pharmacy-acquisition-cost survey — what pharmacies pay. ASP (Average Sales Price) is the CMS Medicare Part B drug-payment file, published quarterly. Medicaid pays is computed by us from CMS State Drug Utilization Data (total reimbursed ÷ units, trailing 12 months) — gross of rebates and inclusive of dispensing fees, so it reflects what Medicaid paid, not an acquisition cost. Medicare drug plans pay is the median negotiated point-of-sale unit cost across plans listing this NDC in the CMS quarterly Prescription Drug Plan pricing files, before rebates. The VA pays is the federal contract price (FSS, and the statutory Big 4 ceiling where listed) from the VA National Acquisition Center pharmaceutical price file. All are free public government data; each measures a different payer, so the figures are not directly comparable.

Packaging — all sizes for this product

Package NDCDescription Per unit Per pack Marketing startMarketing endStatus
00904-7142-12 0904-7142-12 Main listing 2 BLISTER PACK in 1 CARTON / 6 SUPPOSITORY in 1 BLISTER PACK $0.3197 / ea $3.84 2021-05-05 — Active
00904-7142-60 You're viewing this 100 BLISTER PACK in 1 CARTON / 1 SUPPOSITORY in 1 BLISTER PACK $0.2969 / ea $29.69 2021-05-05 — Discontinued by firm

This pack has the lowest per-ea cost of the 2 priced pack sizes ($0.2969 NADAC).

This pack shows little to no recent Medicaid volume — a different pack size carries most fills. See all packs ↓

Pack size FAQ

What quantity is in this package?
This package contains 100 suppositories — 100 blister pack in 1 carton / 1 suppository in 1 blister pack.
How does this package differ from NDC 00904-7142-12?
Both are Bisacodyl 10 mg Suppository — the drug itself is identical. This page's package is the 100 suppositories one, while NDC 00904-7142-12 is the 12 suppositories package. Per-ea NADAC also differs: $0.2969 here vs $0.3197 for the 12 suppositories pack.
What NDC number is used to bill for this package of Bisacodyl 10 mg Suppository?
Use the 11-digit billing form listed in the identifiers section of this page. Pharmacy and medical claims use the 11-digit form; the FDA label may print a shorter form of the same code.

Prices are the latest CMS NADAC pharmacy acquisition cost per NDC; per-pack figures are per-unit × pack quantity, shown only when the pack is denominated in the same measure NADAC prices.

Therapeutic equivalents

ProductLabelerPackNADAC/unitTEStatusPrice vs. this
Bisacodyl 10 mgthis 00904-7142-60 Major 100 suppositories $0.297 — Discontinued —
Bisacodyl 10 mg 00574-7050-12 Padagis 12 suppositories $0.320 — Availability likely +8%
Good Neighbor Pharmacy Gentle Laxative 10 mg/2000mg 46122-0608-51 AmerisourceBergen 40 mg $0.320 — Availability likely +8%
Bisacodyl 10 mg 57237-0327-03 Rising 30 suppositories $0.320 — Availability likely +8%
Proctozone-B 10 mg 57237-0337-03 Rising 30 suppositories $0.320 — Availability likely +8%
Bisacodyl 10 mg 70000-0573-01 Cardinal 4 suppositories $0.320 — Availability likely +8%
Foster and Thrive Gentle Laxative 10 mg/2000mg 70677-1091-01 Strategic 40 mg $0.320 — Availability likely +8%
Walgreens Gentle Laxative 10 mg 00363-0466-04 Walgreens 40 mg — — FDA listed —
Walgreens Gentle Laxative 10 mg 00363-0468-04 Walgreens 4 suppositories — — FDA listed —
Rite-Aid Gentle Laxative 10 mg 11822-4890-05 RITE 8 suppositories — — FDA listed —
Gentle Laxative Bisacodyl 10 mg 13709-0321-01 NeilMed 30 capsules — — FDA listed —
Bisacodyl Laxative 10 mg/1.8g 13709-0328-01 Neilmed 1.8 g — — FDA listed —
HEB Gentle Laxative 10 mg/2000mg 37808-0877-08 H 40 mg — — FDA listed —
Dulcolax Laxative 10 mg 41167-0210-01 Chattem, 4 suppositories — — FDA listed —
Meijer Gentle Laxative 10 mg/2000mg 41250-0665-04 Meijer 40 mg — — FDA listed —
Discount Drugmart Gentle Laxative 10 mg/2000mg 53943-0805-08 Discount 40 mg — — FDA listed —
Dollar General Gentle Laxative 10 mg/2000mg 55910-0457-04 Dolgencorp, 40 mg — — FDA listed —
Bisacodyl 10 mg 57896-0443-01 GERI-CARE 100 suppositories — — FDA listed —
Stratuscare Bisacodyl 10 mg 58980-0415-04 Stratus 4 suppositories — — FDA listed —
CVS Gentle Laxative 10 mg 59779-0107-09 CVS 8 suppositories — — FDA listed —
Bisacodyl 10 mg 68016-0084-08 Pharmacy 8 suppositories — — FDA listed —
Bisacodyl 10 mg 69842-0816-04 CVS 4 suppositories — — FDA listed —
Laxative 10 mg 70795-1010-01 GRAXCELL 100 suppositories — — FDA listed —
OneLAX 10 mg 71399-8460-02 AKRON 12 suppositories — — FDA listed —
Conlax 10 mg 72701-0102-04 Bliss 4 suppositories — — FDA listed —
Bisacodyl 10 mg 82568-0028-02 AARNA 12 suppositories — — FDA listed —
Bisacodyl 10 mg 83720-0550-25 Oncor 12 suppositories — — FDA listed —
Bisacodyl Laxative 10 mg 71457-0501-01 InvaDerm 102 suppositories — — FDA listed —
About this product: other versions of the same ingredient, strength and form are listed above, least expensive first, with FDA equivalence ratings where available.
Where does this data come from?
Equivalents are other NDCs of the same ingredient, form and route from the openFDA NDC Directory, ranked least-expensive-first by NADAC. Therapeutic-equivalence (AB) ratings come from the FDA Orange Book; biologics use the FDA Purple Book for biosimilar & interchangeable status.

Availability & generic status

🏛️
2021
On the market since
May 2021
📍
2026
Currently FDA-listed
5 years listed
🔒
·
No generic listed yet
brand only
ℹ️No FDA-approved generic found

We did not find an FDA-approved generic match for this exact strength, form and route.

Where does this data come from?
Patents and exclusivity from the FDA Orange Book (small-molecule drugs), refreshed from public FDA data. Generic launch timing is an estimate, not a guarantee.

Inactive Ingredients / Excipients

Inactive ingredients, also called excipients, are components of the drug product other than the active ingredient. They may include fillers, dyes, coatings, preservatives, flavors, or other formulation ingredients.

🧪 Avoiding an ingredient? See Bisacodyl inactive ingredients by manufacturer: every current product's list side by side, so you can ask your pharmacy for the version that does not list it.

💡 Tap an ingredient (hover on desktop) to see what it is and why it’s used.

  • UNII FM8D1RE2VP
    A plant-based oil that has been chemically hardened to stay solid at room temperature. It works as a binder and lubricant to hold tablet ingredients together and help them release properly during digestion.

1 inactive ingredient listed in the exact product block matched to this NDC.

The official label also stateshydrogenated vegetable oil

Label-section wording can be broader than the structured product block and may mention additional formulation ingredients.

Where does this data come from?
Data sourced from official FDA Structured Product Labeling (SPL) via DailyMed — ingredient classCode="IACT" elements from the exact product block matched by this NDC. Label-section narrative from DailyMed / the openFDA label index is shown separately when available.

Inactive ingredient FAQ

Are inactive ingredients the same for every manufacturer?
No. Inactive ingredients can differ by manufacturer, dosage form, strength, and package / product version.
Why might an inactive ingredient be missing?
Some SPLs do not provide a complete structured inactive-ingredient list, and older or unusual labels may only include the information in narrative text.
Can inactive ingredients matter?
Yes. They can matter for allergies, intolerances, dyes, gluten / lactose concerns, preservatives, and formulation differences — but confirm with a pharmacist or the manufacturer when it’s clinically important.

Manufacturer & labeler

LabelerMajor Pharmaceuticals
FDA applicationM007 (OTC MONOGRAPH DRUG)
Labeler code00904
First marketedMay 2021
Product typeHuman Otc Drug
Portfolio630 products on file
The labeler markets the product; the application holder owns the FDA approval. They’re often the same company but can differ (e.g. a repackager or an authorized generic). A mailing address / phone appears here when the manufacturer includes it in the product’s FDA label (not all do).
Where does this data come from?
Labeler, application holder and registered establishment from the FDA openFDA NDC Directory and Drugs@FDA; address/contact from the product’s FDA label.

FDA label — Drug Facts FDA SPL

The complete FDA label for this product — the official Drug Facts labeling, verbatim, section by section. Jump with a chip, search within the label, or expand everything.
🎯 Indications and Usage 21 words ▾

Uses for temporary relief of occasional constipation and irregularity this product generally produces bowel movement in 15 minutes to 1 hour

⏱️ Dosage and Administration 70 words ▾

Directions Adults and children 12 years of age and over - One suppository once daily Children 6 to under 12 years of age - 1/2 suppository once daily Children under 6 - Ask a doctor Detach one suppository from the strip and remove the foil Carefully insert one suppository well into the rectum, pointed end first Do not use more than once per day Retain about 15 to 20 minutes

⚠️ Warnings 169 words ▾

Warnings For rectal use only Do not use more than once per day for a period longer than one week unless directed by a doctor laxative products when abdominal pain, nausia, or vomiting are present unless directed a doctor Ask a Doctor before using any laxative if you have notice a sudden change in bowel habits that lasts more than 2 weeks When using this product may cause stomach discomfort, faintness, rectal burning and mild cramps Stop use and ask a doctor if you have rectal bleeding or fail to have a bowel movement after using a laxative.

These may indicate a serious condition. If pregnant or breast feeding, ask a health professional before use. Keep out of reach of children.

If swallowed, get medical help or contact a Poison Control Center (1-800-222-1222) right away.

Do not use more than once per day for a period longer than one week unless directed by a doctor laxative products when abdominal pain, nausia, or vomiting are present unless directed a doctor

🧪 Active Ingredient 8 words ▾

Active ingredient (in each suppository) Bisacodyl USP, 10mg

🧪 Inactive Ingredients 5 words ▾

Inactive ingredients hydrogenated vegetable oil

🎯 Purpose 3 words ▾

Purpose Stimulant Laxative

📄 Ask a Doctor Before Use If 23 words ▾

Ask a Doctor before using any laxative if you have notice a sudden change in bowel habits that lasts more than 2 weeks

📄 When Using This Product 14 words ▾

When using this product may cause stomach discomfort, faintness, rectal burning and mild cramps

📄 Stop Use and Ask a Doctor If 28 words ▾

Stop use and ask a doctor if you have rectal bleeding or fail to have a bowel movement after using a laxative. These may indicate a serious condition.

🤰 If Pregnant or Breast-Feeding 11 words ▾

If pregnant or breast feeding, ask a health professional before use.

📄 Keep Out of Reach of Children 20 words ▾

Keep out of reach of children. If swallowed, get medical help or contact a Poison Control Center (1-800-222-1222) right away.

📄 Other Information 23 words ▾

Other information Storage temperature not to exceed 30ºC (86ºF) Indiviually sealed for your protection. Do not use if foil is torn or open.

📄 Questions or Comments 5 words ▾

Questions or comments? (800) 616-2471

📄 Package Label / Principal Display Panel 36 words ▾

Major Bisacodyl Suppositories Major_Bisacodyl_12.jpg The product package shown above represents a sample of that currently in use. Additional packaging may also be available. Bisacodyl Suppositories 12ct Distributed by Major Pharmaceuticals Livonia, MI 48152 Major Bisacodyl 12

Source: FDA Structured Product Labeling, mirrored from DailyMed / openFDA. Prefer the government’s original formatting? View this label on DailyMed ↗

Medicaid utilization by pack size

Medicaid (SDUD) totals over the four most recent reported quarters for every package size of this drug — handy when a specific package (e.g. a starter/titration pack) carries little or no Medicaid volume on its own.
Drug total (last 4 qtrs): 6,290 Rx · 116,981 units · $81,594 gross reimbursed
Tap a pack size to open its page. Source: CMS State Drug Utilization Data, last 4 quarters.

About this NDC listing & data coverage

Over-the-counter (OTC) product No longer marketed (per FDA listing data)
What data is (and isn’t) available for this NDC — tap to expand
NDC identity (package / product / labeler codes) ✓ Available
Labeler ✓ Available
Product & package description ✓ Available
Marketing category & status ✓ Available
Active ingredient / dosage form / route ✓ Available
FDA label (SPL via DailyMed) ✓ Available
Package photos ✓ Available
Inactive ingredients (structured) ✓ Available
NADAC pharmacy acquisition price (CMS) ✓ Available
Orange Book / therapeutic-equivalence data — Not published for this NDC Applies only to products approved under an NDA/ANDA; many listings are out of scope.
HCPCS J-code billing crosswalk — Not published for this NDC Most self-administered / retail products have no J-code — that is normal.
Medicaid utilization (CMS SDUD) — Not published for this NDC CMS reports utilization only for NDCs with Medicaid claims above its privacy threshold.
“Not published” reflects what the public FDA / CMS / NLM sources provide for this exact package code — it is a property of the data feeds, not a judgment about the product.

Questions about this listing

Is this NDC FDA-approved?
An NDC listing does not by itself establish FDA approval — the NDC Directory records that a product is listed with FDA, not that it was reviewed and approved. This listing's marketing category is "Otc Monograph Drug". Products approved under an application carry an NDA, ANDA, or BLA number.
What does the discontinued status mean for this NDC?
The labeler reported a marketing end date (or the listing was delisted), so this specific package is no longer actively marketed. Remaining stock may still be dispensed for a time, and the NDC stays valid for historical records and claims — but data feeds (pricing, labeling) typically stop updating for it. Other package sizes or other manufacturers' versions of the same medication may still be marketed — see the equivalents section where available.
Is the NDC printed on the package the same as the 11-digit billing NDC?
Yes, they identify this exact package in different formats. The form printed on the packaging and shown on DailyMed is the one the FDA registered. Insurance claims use a fixed 11-digit 5-4-2 format, so the short segment is padded with a leading zero and the dashes are dropped. The Identity section at the top of this page lists each form of this code.
Does this product come in other package sizes?
Yes — the FDA directory lists 1 other package presentation of this same product, including 12 suppositories (00904-7142-12). Each has its own NDC and its own page — see the package list near the top of this page.
Who lists this product with the FDA?
Major Pharmaceuticals is the labeler of record for this NDC — the company under whose FDA-assigned code the package is listed. The labeler may be the manufacturer itself or a distributor marketing the product under its own code.
Do I need a prescription for this product?
This NDC is listed with FDA as an over-the-counter product, so it does not require a prescription. Follow the package directions, and ask your pharmacist if you are unsure whether it is right for you.
This page identifies an FDA-listed package (the NDC) and reports public regulatory and pricing data about the listing. It is reference information, not a medical recommendation — talk to your pharmacist or prescriber about your own medication.
Where does this data come from?
Listing facts (marketing category, packager status, marketing dates) from the FDA openFDA NDC Directory; label availability from DailyMed; pricing coverage from CMS NADAC; equivalence scope from the FDA Orange Book.
For educational and professional reference only — not medical advice. Pricing reflects published NADAC and CMS ASP (free public data) and may differ from your acquisition cost; always verify before billing or dispensing.